Concepedia

Zhongwei Hu

ZH

Statistics

Publications

1

Citations

88

H-Index

1

Active since

2023

Affiliations

Shanghai Cancer Institute(Current)

Zhongwei Hu is an author at Shanghai Cancer Institute specializing in oncology, synthetic lethality, and signal transduction in cancer.

ORCID

Publications per year

2023–2023

1

Publications

1

Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer

Juanjuan Feng, Zhongwei Hu, Xinting Xia et al. · Oncogene · 2023 · 88 citations · Full text

, , +17

1–1 of 1